Abstract
Novas discusses the implications of a new study in PLoS Medicine, in which executives and senior managers from bioscience firms were asked what their companies were doing to promote ethical behaviour.
What is the bioscience industry doing to address the ethical issues it faces?
生物科技产业正在采取哪些措施来解决其面临的伦理问题？
阅读：1
| 期刊： | PLoS Medicine | 影响因子： | 9.900 |
| 时间： | 2006 | 起止号： | 2006 May;3(5):e142 |
| doi： | 10.1371/journal.pmed.0030142 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。
2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。
4、投稿及合作请联系：info@biocloudy.com。